Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

EMEUNET Podcast

Peresolimab in RA – new name, new pathway, new opportunity? - With Dr. Jay Tuttle

12 Oct 2023

Description

Join Philipp Bosch and Pierre-Antoine Juge as they discuss hot topics in rheumatology with special guests. This week an interview with Dr. Jay Tuttle. This PD-1 inhibitor was investigated by Dr. Tuttle and his team in a phase 2a RCT published in the NEJM. Dr. Tuttle also share about his career in the industry and how he is now responsible for developing clinical trials! Editorial Team: Dr Renske Meijer, Dr Bayram Farisogullari, Dr Olivier Fakih, Dr Mrinalini Dey.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.